NCT05763732 Effects of RAS on Gait in PD Patients With DBS
| NCT ID | NCT05763732 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Johns Hopkins University |
| Condition | Parkinson Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2023-08-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2023-08-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Participants will be asked to walk along with the metronome beats (RAS) during the participants' stimulation state (ON or OFF) for four minutes for each state. The researcher will collect the gait parameters (cadence, velocity, and stride length) of patients before, during, and after RAS in both DBS ON and OFF states. Using MDS-UPDRS, participants' gait patterns will be collected before and after RAS while both DBS is ON and OFF. Electrophysiological activity (local field potentials, LFPs) will be collected across all stages (pre, during, and post-RAS) of evaluation.
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with Parkinson disease (PD) (and) * PD patients who implanted Deep Brain Stimulation (DBS) of the subthalamic nucleus (STN) with PerceptTM PC Exclusion Criteria: * Inability or unwillingness to follow directions for study procedures
Contact & Investigator
Alexander Pantelyat, MD
PRINCIPAL INVESTIGATOR
Johns Hopkins University
Frequently Asked Questions
Who can join the NCT05763732 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 89 Years, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05763732 currently recruiting?
Yes, NCT05763732 is actively recruiting participants. Contact the research team at apantel1@jhmi.edu for enrollment information.
Where is the NCT05763732 trial being conducted?
This trial is being conducted at Baltimore, United States.
Who is sponsoring the NCT05763732 clinical trial?
NCT05763732 is sponsored by Johns Hopkins University. The principal investigator is Alexander Pantelyat, MD at Johns Hopkins University. The trial plans to enroll 10 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.